ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1306

Improving Osteoporosis Screening in Individuals of Color

Megan Brochu1, Kristofer Marcus1, Sarah Latorre1, Francis Wanjau1, Arvin Garg2, Eric Alper2, Rulan Lyu1, Tracey Wilkie1 and Jonathan Cheah3, 1UMass Memorial Health, Worcester, MA, 2UMass Memorial Health, UMass Chan Medical School, Worcester, MA, 3UMass Chan Medical School, Worcester, MA

Meeting: ACR Convergence 2022

Keywords: Access to care, Disparities, osteoporosis, primary care

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Osteoporosis, including the clinical event of fragility fracture is an ever-increasing public health burden. Effective screening techniques and well as therapies to reduce future fracture risk are well defined and readily available. The US Preventative Services Task Force recommends screening for osteoporosis in all women age 65 and over. However, it has been well described that screening rates, especially in non-white compared to white populations are low. The aim of this work is to improve the screening rates for osteoporosis through dual-energy x-ray absorptiometry (DXA), focusing on non-white individuals across a single academic health system.

Methods: Within a single academic health system, two specific interventions were implemented starting in the summer/fall of 2021 to increase the rates of osteoporosis screening in women age 65 and over with a specific target of increasing osteoporosis screening in non-white populations by 4% by the end of the time period October 2021 – September 2022. First, system-wide, a Care Gap was implemented in the electronic health record to notify PCPs at the time of a patient visit that an individual did not have a DXA result within the electronic health record. Second, specific primary care practices with the highest rates of non-white women age 65 and over without a recorded DXA were targeted and received individualized lists of their patients without osteoporosis screening and with institutional support, a care pathway was developed to then directly contact, counsel and then if agreeable arrange for DXA screening. Cumulative screening rates in the target population were calculated monthly from the time of implementation.

Results: At baseline (October 2020 – September 2021), 50.4% of non-white women age 65 and over had received DXA testing, compared to 64.3% of white women. With the implementation of the Care Gap in July 2021 and targeted interventions within 10 Primary Care Practices starting in September 2021, total screening rates in non-white individuals has improved month by month to a current documented screening rate of 57% (Figure 1), exceeding the initial target goal of the initiative. While screening in all racial groups have improved over time, Black or African-American individuals continue to have much lower overall screening rates (46.8%), compared to their white (67.5%), Asian (62.7%) and Hispanic (61.5%) counterparts (Figure 2).

Conclusion: Using both general and specific interventions to target underrepresented populations is able to improve screening rates for osteoporosis. Additional work will focus on eliminating racial inequalities with screening as well as ensuring that those who are screen positive are linked into osteoporosis care.

Supporting image 1

Figure 1: overall documented osteoporosis screening rates in non-white women

Supporting image 2

Figure 2: overall documented osteoporosis screening rates across different racial groups


Disclosures: M. Brochu, None; K. Marcus, None; S. Latorre, None; F. Wanjau, None; A. Garg, None; E. Alper, None; R. Lyu, None; T. Wilkie, None; J. Cheah, None.

To cite this abstract in AMA style:

Brochu M, Marcus K, Latorre S, Wanjau F, Garg A, Alper E, Lyu R, Wilkie T, Cheah J. Improving Osteoporosis Screening in Individuals of Color [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/improving-osteoporosis-screening-in-individuals-of-color/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-osteoporosis-screening-in-individuals-of-color/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology